ArticlePloS one2025

Improved drug-screening tests of candidate anti-cancer drugs in patient-derived xenografts through use of numerous measures of tumor growth determined in multiple independent laboratories.

Elizabeth Rosenzweig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.